To Upload your aptamers in our database
For LOGIN
# | Aptamer Name | Aptamer Target (General) | Aptamer Target (Specific) | Length | Affinity | Buffer | GC Content | Sequence | Reference |
---|---|---|---|---|---|---|---|---|---|
121 | Interleukin-17A/F (IL-17A/F) (APTAF42) | Protein | Human Interleukin-17A/F | 69 | 72.2 nM | Binding Buffer (145 mM sodium chloride, 5.4 mM potassium chloride, 0.8 mM magnesium chloride, 1.8 mM calcium chloride, 20 mM Tris–HCl (pH 7.6) supplemented with 0.05% Tween20 | 59.42% | 5'-GGGCUAGCUGAUCGUACCCAGUAGCGUGGCAUGGGGUGCCUAGUCGGGCGAUACUAACAGCUAACACCC-3' | Adachi, H., et al. "Antagonistic RNA aptamer specific to a heterodimeric form of human interleukin-17A/F." Biochemie, 93 (2011): 1081-1088. |
122 | Keratinocyte Growth Factor (14F) | Protein | Keratinocyte Growth Factor (KGF) | 69 | 0.3 pM | Binding Buffer (DPBS, 0.5 mM MgCl2, 0.2% BSA, 0.02% sodium azide for PC-3, serum-free MEM growth medium, 0.1% BSA, 25 mM HEPES (pH 7.4), 1 ug/ml heparin for NIH3T3/KGFR) | 56.52% | 5'-GGGAGGACGAUGCGGUGGUCUCCCAAUUCUAAACUUUCUCCAUCGUAUCUGGGCAGACGACUCGCCCGA-3' | Pagratis, N., et al. "Potent 2'-amino-, and 2'-fluoro-2'- deoxyribonucleotide RNA inhibitors of keratinocyte growth factor." Nature Biotechnology, 25(1997):68-73. |
123 | Clone 1 | Protein | Protein E (PE) | 69 | 165 ug (~5 nmol) purified truncated His-tagged PE immobilized on Ni–NTA agarose (Qiagen) in 1.6 mL PBSM (PBS with 1 mM MgCl2) | 63.77% | 5?-CGACTGCAGAGCTTGCTACGTGATCAAATCGAGCTTTAACCCAACAGAGCATCCGTATCTATCCAAATGGGTACCGAGCTCGAATTCCC-3? | Barfod, Anders et al. "In Vitro Selection of RNA Aptamers Directed Against Protein E: A Haemophilus influenzae Adhesin." Mol Biotech, 2014: 1-12 | |
124 | MCP-1 (ADR7) | Protein | Monocyte chemoattractant protein-1 (mouse) | 70 | 180 pM | Selection Buffer (110 mM NaCl, 1 mM MgCl2, 20 mM HEPES (pH 7.0), 1 mM CaCl2, 5 mM KCl, 0.001% HSA, 0.05% Tween 20) | 62.86% | 5'-GGGAGGACGAUGCGGGAACUCACCGGGAAGAAGCCCGUUCCGUCACAGACAUGUUCCGCAUCGUCCUCCC-3' | Rhodes, Andrew, et al. "The generation and characterisation of antagonist RNA aptamers to MCP-1." FEBS Letter, 506 (2001): 85-90. |
125 | OSM (ADR58) | Protein | Human Oncostatin M (OSM) | 70 | 7 nM | Wash Buffer: 0.1% I-block, 0.05% Tween 20 in SCHMK buffer (110 mM NaCl, 1 mM MgCl2, 20 mM HEPES (pH 7.0), 1 mM CaCl2, 5 mM KCl) | 68.57% | 5'-GGGAGGACGAUGCGGAUCGCCCUGAACCGGCCCAGCAGACUGCUGACGGCACGAUCCGCAUCGUCCUCCC-3' | Rhodes, Andrew, et al. "The generation and characterization of antagonist RNA aptamers to human oncostatin M." Journal of Biological Chemistry, 275 (2000): 28555-28561. |
126 | Neurotensin receptor NTS-1 (P19) | Protein | Neurotensin receptor NTS-1 | 70 | 0.37 nM | Binding Buffer (SHMCK buffer containing 0.1% (w/v) HSA, 0.2% (w/v) CHAPS, 0.04% (w/v) CHS, and 0.1% (w/v) LM) | 60.00% | 5'-GGGAGGACGAUGCGGACAGAUACGGAACUACAGAGGUCAAUUACGGUGGCCACGCAGACGACUCGCCCGA-3' | Daniels et al. "Generation of RNA Aptamers to the G-Protein-Coupled Receptor for Neurotensin, NTS-1." Journal of Analytical Biochemistry, 305(2002): 214-226. |
127 | Cyclophilin B (M9-5) | Cells | Cyclophilin B (CypB) pancreatic cell line | 71 | 1.5 nM | Buffer F: 20 mM HEPES pH 7.5, 150 mM NaCl, 2mM CaCl2, and 3 mM MgCl2 | 69.01% | 5'-GGGAGGACGAUGCGGGGACCUAUGCAGUAGCCAGUGUGGACUGGGCUGCCCCCCCCAGACGACUCGCCCGA-3' | Ray, P. (2012). Comparing human pancreatic cell secretomes by in vitro aptamer selection identifies cyclophilin b as a candidate pancreatic cancer biomarker. J. Clin. Invest., 122(5), 1734-1741. doi: 10.1172/JC162385 |
128 | Brain Penetrating Aptamer (A15) | Tissue | Brain capillary endothelia and parenchyma | 71 | N/A nM | SELEX selection buffer: 10 mM HEPES (pH 7.4), 50 mM NaCl, 1 mM MgCl2, 1 mM CaCl2, 0.01% bovine serum albumin. | 59.15% | 5'-GGGAGGACGAUGCGGCGUAUUGCGCGAGGAUUAUCCGCUCAUCGUUGUUGUUGUGCAGACGACUCGCCCGA-3' | Cheng C, B Davidson, et al. (2013) In vivo SELEX for identification of brain-penetrating aptamers. Molecular Therapy - Nucleic Acids 2: e67. |
129 | von Willebrand Factor (VWF R9.3) | Protein | von Willebrand Factor (VWF) | 76 | 1.2 nM | Selection Buffer E (20mM HEPES (pH 7.4), 50 mM NaCl, 2 mM CaCl2, and 0.1% BSA) | 57.89% | 5'-GGGAGGACGAUGCGGAUCGCGCUCUCCUGCUUAAGCAGCUAUCAAAUAGCCCACUCAGACGACUCGCUGAGGAUCC-3' | S Oney, BA Sullenger, et al. (2007) "Antidote-Controlled Platelet Inhibition Targeting von Willebrand Factor with Aptamers." Oligonucleotides, 17:265-274. |
130 | Human Wild-type PAI-1 (WT-15) | Protein | Human Wild-type PAI-1 | 76 | 177 pM | Binding Buffer E( 20 mM HEPES (pH 7.4), 50 mM NaCl, 2 mM CaCl2, and 0.05% CHAPS) | 53.95% | 5'-GGGAGGACGAUGCGGAUCAACUCACCGUAGGUCUAGUGAGAACUUCAAGUCUACUCAGACGACUCGCUGAGGAUCC-3' | Blake et al. "Antimetastatic Potential of PAI-1-Specific RNA Aptamers." Oligonucleotides, 19(2009): 117-128. |